Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · IEX Real-Time Price · USD
1.650
+0.020 (1.23%)
Jul 22, 2024, 10:08 AM EDT - Market open
Processa Pharmaceuticals Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$6.00
Upside
+263.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +384.85% | Jun 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +384.85% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +384.85% | Apr 25, 2024 |
| Benchmark | Benchmark | Buy Reiterates $4 | Buy | Reiterates | $4 | +142.42% | Mar 6, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 17, 2023 |
| Benchmark | Benchmark | Buy Maintains $180 → $80 | Buy | Maintains | $180 → $80 | +4,748.48% | Apr 4, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $100 → $60 | Buy | Maintains | $100 → $60 | +3,536.36% | Apr 3, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $180 → $100 | Strong Buy | Maintains | $180 → $100 | +5,960.61% | Jan 12, 2023 |
| Maxim Group | Maxim Group | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +10,809.09% | Apr 19, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $400 | Buy | Initiates | $400 | +24,142.42% | Aug 3, 2021 |
| Oppenheimer | Oppenheimer | Buy Initiates $400 | Buy | Initiates | $400 | +24,142.42% | Aug 2, 2021 |